Anterix (ATEX) Current Deferred Revenue (2014 - 2026)

Anterix (ATEX) has reported Current Deferred Revenue for 13 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $14.5 million, down 88.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (down 88.36% YoY), and the FY2026 annual result was $14.5 million, down 88.36% from the prior year.
• Current Deferred Revenue was $14.5 million for Q1 2026 at Anterix, down from $132.6 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $132.6 million in Q4 2025 and troughed at $6.0 million in Q4 2024.
• Average Current Deferred Revenue over 5 years is $75.6 million, with a median of $60.8 million recorded in 2023.
• Year-over-year, Current Deferred Revenue jumped 7273.54% in 2022 and slumped 88.36% in 2026.
• Over 5 years, Current Deferred Revenue stood at $8.0 million in 2022, then declined by 13.75% to $6.9 million in 2023, then declined by 13.59% to $6.0 million in 2024, then jumped by 2124.02% to $132.6 million in 2025, then tumbled by 89.05% to $14.5 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $14.5 million in Q1 2026, $132.6 million in Q4 2025, and $130.4 million in Q3 2025.